ORIGIN MATERIALS INC (ORGN) Stock Fundamental Analysis
NASDAQ:ORGN - Nasdaq - US68622D1063 - Common Stock - Currency: USD
We assign a fundamental rating of 2 out of 10 to ORGN. ORGN was compared to 85 industry peers in the Chemicals industry. While ORGN seems to be doing ok healthwise, there are quite some concerns on its profitability. ORGN does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year ORGN has reported negative net income.
In the past year ORGN has reported a negative cash flow from operations.
In multiple years ORGN reported negative net income over the last 5 years.
In the past 5 years ORGN always reported negative operating cash flow.
1.2 Ratios
ORGN has a worse Return On Assets (-27.57%) than 87.06% of its industry peers.
With a Return On Equity value of -30.59%, ORGN is not doing good in the industry: 76.47% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -27.57% | ||
| ROE | -30.59% | ||
| ROIC | N/A |
ROA(3y)-0.36%
ROA(5y)-11.35%
ROE(3y)0.58%
ROE(5y)-6056.88%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 1.31%, ORGN is doing worse than 88.24% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for ORGN so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 1.31% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
ORGN does not have a ROIC to compare to the WACC, probably because it is not profitable.
ORGN has more shares outstanding than it did 1 year ago.
ORGN has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.71, we must say that ORGN is in the distress zone and has some risk of bankruptcy.
ORGN has a Altman-Z score of 0.71. This is in the lower half of the industry: ORGN underperforms 77.65% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that ORGN is not too dependend on debt financing.
The Debt to Equity ratio of ORGN (0.01) is better than 91.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.71 |
ROIC/WACCN/A
WACC10.54%
2.3 Liquidity
A Current Ratio of 9.51 indicates that ORGN has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 9.51, ORGN belongs to the top of the industry, outperforming 98.82% of the companies in the same industry.
ORGN has a Quick Ratio of 9.44. This indicates that ORGN is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of ORGN (9.44) is better than 98.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 9.51 | ||
| Quick Ratio | 9.44 |
3. Growth
3.1 Past
The earnings per share for ORGN have decreased strongly by -4035225266123964928.00% in the last year.
ORGN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.91%.
EPS 1Y (TTM)-4035225266123965000%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80%
Revenue 1Y (TTM)-11.91%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-20.44%
3.2 Future
The Earnings Per Share is expected to grow by 16.99% on average over the next years. This is quite good.
ORGN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 87.52% yearly.
EPS Next Y10.75%
EPS Next 2Y15.81%
EPS Next 3Y17.39%
EPS Next 5Y16.99%
Revenue Next Year46.92%
Revenue Next 2Y89.65%
Revenue Next 3Y96.88%
Revenue Next 5Y87.52%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
ORGN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ORGN. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
ORGN's earnings are expected to grow with 17.39% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.81%
EPS Next 3Y17.39%
5. Dividend
5.1 Amount
No dividends for ORGN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
0.44
-0.01 (-2.53%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners18.59%
Inst Owner Change-12.88%
Ins Owners5.07%
Ins Owner Change8.24%
Market Cap65.97M
Analysts45.71
Price Target1.27 (188.64%)
Short Float %2.5%
Short Ratio2.7
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-38.15%
Min EPS beat(2)-96.08%
Max EPS beat(2)19.79%
EPS beat(4)1
Avg EPS beat(4)-31.09%
Min EPS beat(4)-96.08%
Max EPS beat(4)19.79%
EPS beat(8)5
Avg EPS beat(8)32.19%
EPS beat(12)9
Avg EPS beat(12)116.34%
EPS beat(16)13
Avg EPS beat(16)141.29%
Revenue beat(2)0
Avg Revenue beat(2)-41.07%
Min Revenue beat(2)-81.71%
Max Revenue beat(2)-0.43%
Revenue beat(4)1
Avg Revenue beat(4)-2%
Min Revenue beat(4)-81.71%
Max Revenue beat(4)77.24%
Revenue beat(8)3
Avg Revenue beat(8)-6.89%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-61.54%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.44%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-18.49%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 2.21 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.21 | ||
| P/tB | 0.21 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.56
EYN/A
EPS(NY)-0.32
Fwd EYN/A
FCF(TTM)-0.38
FCFYN/A
OCF(TTM)-0.28
OCFYN/A
SpS0.2
BVpS2.1
TBVpS2.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -27.57% | ||
| ROE | -30.59% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 1.31% | ||
| FCFM | N/A |
ROA(3y)-0.36%
ROA(5y)-11.35%
ROE(3y)0.58%
ROE(5y)-6056.88%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 127.73% | ||
| Cap/Sales | 46.87% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 9.51 | ||
| Quick Ratio | 9.44 | ||
| Altman-Z | 0.71 |
F-Score3
WACC10.54%
ROIC/WACCN/A
Cap/Depr(3y)4824.97%
Cap/Depr(5y)3442.25%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4035225266123965000%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80%
EPS Next Y10.75%
EPS Next 2Y15.81%
EPS Next 3Y17.39%
EPS Next 5Y16.99%
Revenue 1Y (TTM)-11.91%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-20.44%
Revenue Next Year46.92%
Revenue Next 2Y89.65%
Revenue Next 3Y96.88%
Revenue Next 5Y87.52%
EBIT growth 1Y-11.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year36.46%
EBIT Next 3Y14.85%
EBIT Next 5Y43.23%
FCF growth 1Y64.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3.05%
OCF growth 3YN/A
OCF growth 5YN/A